Changeflow GovPing Healthcare Oxygen Concentrator with Flow Path Switching Va...
Routine Notice Added Final

Oxygen Concentrator with Flow Path Switching Valve Monitoring

Favicon for changeflow.com USPTO Patent Applications - Medical Devices (A61M)
Published
Detected
Email

Summary

USPTO published patent application US20260097353A1 for Teijin Pharma Limited covering an oxygen concentrator with monitoring means to detect flow path switching valve abnormalities using pressure sensor outputs. The invention addresses detecting valve issues upstream of the concentrator from pressure waveforms in the product tank.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

USPTO published patent application US20260097353A1 for an oxygen concentrator with a monitoring system that detects abnormalities in flow path switching valves. The system monitors valve conditions based on pressure sensor outputs in the product tank and triggers abnormality detection when pressure values fall outside predetermined thresholds during adsorption or desorption steps.

Manufacturers of oxygen concentrators and related medical equipment should monitor this patent for potential licensing implications or design considerations. Competitors developing pressure-based monitoring systems for similar devices may need to evaluate freedom-to-operate risks.

What to do next

  1. Monitor for updates on patent prosecution

Archived snapshot

Apr 10, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

OXYGEN CONCENTRATOR

Application US20260097353A1 Kind: A1 Apr 09, 2026

Assignee

Teijin Pharma Limited

Inventors

Yuta MORISHITA, Yoshihiro MUROSHIGE

Abstract

An oxygen concentrator is provided with a monitoring means for monitoring conditions of the flow path switching means based on the output of the pressure sensor in the product tank, and detects an abnormality of the flow path switching valve when a detected value of the pressure sensor during the adsorption step and/or desorption step falls outside a predetermined threshold range. The problem of detecting an abnormality in a flow path switching valve upstream of an oxygen concentrator from the waveform of a pressure sensor provided in a product tank is thereby addressed.

CPC Classifications

B01D 53/053 A61M 16/101 A61M 16/16 C01B 13/0259 B01D 2256/12 B01D 2257/102 B01D 2258/06 B01D 2259/40009 B01D 2259/4533

Filing Date

2023-09-19

Application No.

19113018

View original document →

Get daily alerts for USPTO Patent Applications - Medical Devices (A61M)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 9th, 2026
Instrument
Notice
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
US20260097353A1

Who this affects

Applies to
Medical device makers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Patent examination IP licensing
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Healthcare

Get alerts for this source

We'll email you when USPTO Patent Applications - Medical Devices (A61M) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!